CD24 and breast cancer: Accumulating evidence supports a role for CD24 in a variety of malignancies, including B-cell lymphoma, renal cell carcinoma, small-cell and non small-cell lung carcinoma, nasopharyngeal carcinoma, hepatocellular carcinoma, bladder carcinoma, epithelial ovarian cancer and breast cancer [3].